tiprankstipranks
Advertisement
Advertisement

IMVT Stock Latest News

Immunovant price target raised to $61 from $57 at Citi
The FlyImmunovant price target raised to $61 from $57 at Citi
19h ago
IMVT
Immunovant price target raised to $47 from $35 at JPMorgan
PremiumThe Fly
Immunovant price target raised to $47 from $35 at JPMorgan
1M ago
IMVT
Immunovant price target raised to $62 from $44 at Guggenheim
PremiumThe Fly
Immunovant price target raised to $62 from $44 at Guggenheim
1M ago
IMVT
Immunovant price target raised to $30 from $23 at Truist
PremiumThe Fly
Immunovant price target raised to $30 from $23 at Truist
1M ago
IMVT
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
PremiumCompany Announcements
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
1M ago
IMVT
Immunovant price target raised to $43 from $32 at BofA
PremiumThe FlyImmunovant price target raised to $43 from $32 at BofA
1M ago
IMVT
Immunovant price target raised to $40 from $35 at H.C. Wainwright
Premium
The Fly
Immunovant price target raised to $40 from $35 at H.C. Wainwright
1M ago
IMVT
Immunovant rises 33.6%
Premium
The Fly
Immunovant rises 33.6%
1M ago
IMVT
This Is Why Immunovant Stock (IMVT) Is Up Today
PremiumMarket News
This Is Why Immunovant Stock (IMVT) Is Up Today
1M ago
IMVT
Immunovant rises 25.9%
PremiumThe Fly
Immunovant rises 25.9%
1M ago
IMVT
Immunovant reports Q4 EPS (73c), consensus (63)
PremiumThe Fly
Immunovant reports Q4 EPS (73c), consensus (63)
1M ago
IMVT
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
PremiumWeekend Updates
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
2M ago
AGX
EYPT
Immunovant price target raised to $32 from $29 at Goldman Sachs
PremiumThe FlyImmunovant price target raised to $32 from $29 at Goldman Sachs
3M ago
IMVT
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
Premium
Weekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
3M ago
SG
VOR
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
Premium
Ratings
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
3M ago
IMVT
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
PremiumThe Fly
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
3M ago
F
BP
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
PremiumRatings
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
3M ago
IMVT
Immunovant price target lowered to $50 from $52 at Leerink
PremiumThe Fly
Immunovant price target lowered to $50 from $52 at Leerink
3M ago
IMVT
Morning Movers: Immunovant sinks after batoclimab trials miss goal
PremiumThe Fly
Morning Movers: Immunovant sinks after batoclimab trials miss goal
3M ago
BP
ALK
Video: Globalstar jumps after report of Amazon deal interest
PremiumThe FlyVideo: Globalstar jumps after report of Amazon deal interest
3M ago
CVX
DAL
Immunovant reports batoclimab clinical studies missed primary endpoint
Premium
The Fly
Immunovant reports batoclimab clinical studies missed primary endpoint
3M ago
IMVT
Bernstein initiates Immunovant with a Market Perform, $28 price target
Premium
The Fly
Bernstein initiates Immunovant with a Market Perform, $28 price target
3M ago
IMVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >